nasdaq

MannKind Stock Soars 39% After New Ralinepag DPI Partnership Expansion With United Therapeutics

by

Safetyslug – MannKind Stock Skyrockets 39% After New Ralinepag DPI Development Deal With United Therapeutics. MannKind (NASDAQ: MNKD) shares surged 39.28% in morning trading after the company unveiled a new dry powder inhalation (DPI) development program for ralinepag in partnership with United Therapeutics Corporation.

The company announced it has developed a dry powder inhaled formulation of ralinepag, known as MNKD-1501, for United Therapeutics under an expanded licensing and collaboration agreement. Under the terms of the deal, MannKind is eligible to receive up to $35 million in development milestone payments, along with 10% royalties on net sales.

Phase 3 Success of Ralinepag Strengthens Commercial Potential

The announcement comes after United Therapeutics reported in March that its pivotal long-term Phase 3 ADVANCE OUTCOMES study of extended-release ralinepag tablets for pulmonary arterial hypertension successfully met its primary endpoint with strong statistical significance.

That clinical success adds major commercial credibility to the new DPI program, as investors now see MNKD-1501 as a potentially valuable inhaled expansion of a clinically validated therapy.

Tyvaso DPI Success Sets a Powerful Benchmark

Investor enthusiasm is also being fueled by MannKind’s prior success with United Therapeutics.

The original 2018 agreement between the two companies led to the successful development and FDA approval of Tyvaso DPI in May 2022. In 2025, United Therapeutics reported that Tyvaso DPI generated $1.3 billion in revenue, establishing a clear benchmark for what MNKD-1501 could potentially achieve if commercialization follows a similar path.

This new announcement also marks a major sentiment reversal from February 2026, when United Therapeutics introduced TreSMI, a soft mist inhaler that directly challenged MannKind’s Tyvaso DPI franchise and contributed to nearly a 40% drop in MannKind shares at the time.

Broader Market Rally and Upcoming Earnings Add Momentum

Today’s move is also supported by a strong broader market backdrop, with:

  • S&P 500 up 1.10%
  • Dow Jones rising 1.28%
  • NASDAQ gaining 1.28%

MannKind is also scheduled to report Q1 2026 earnings on May 6 after market close, adding another major near-term catalyst that is drawing investor attention.

Analyst Outlook Remains Mixed but Suggests Undervaluation

Wall Street coverage has been somewhat mixed:

  • H.C. Wainwright lowered its target price from $11 to $8 while maintaining a Buy rating
  • Leerink Partners maintained its Outperform rating, signaling continued confidence that the stock may be undervalued

Despite prior caution, today’s partnership expansion substantially reshapes the narrative around MannKind’s future growth.

Why MNKD Is Rallying So Sharply Today

The new ralinepag DPI deal reframes MannKind’s relationship with United Therapeutics as an evolving growth partnership rather than a competitive threat.

Key bullish drivers include:

  • Immediate $5 million payment
  • Up to $35 million in milestone opportunities
  • 10% royalty rights on net sales
  • A Phase 3-backed drug candidate
  • Proven precedent from Tyvaso DPI’s billion-dollar revenue trajectory
  • Upcoming Q1 earnings catalyst

Together, these factors created a powerful catalyst mix that is driving MannKind sharply higher today.

Watching MNKD for a Trading Setup?

Many traders can identify chart patterns, but execution timing is often the real challenge.

Advanced visual AI trading tools are increasingly helping traders bridge that confidence gap by analyzing chart structures in real time and generating actionable strategies — including entry points, stop-losses, and profit targets in under a minute, offering clearer next steps when momentum opportunities like MNKD emerge.

Western Digital Stock Soars After Blowout Q3 FY2026 Earnings and Major Analyst Upgrades

by

Western Digital Stock Surges to 52-Week High Following Blowout Q3 FY2026 Earnings – Western Digital (NASDAQ: WDC) shares surged 5.79% during today’s trading session, climbing to $467.98 and reaching a new 52-week high of $480.11 as investors continued to reward the company’s exceptional fiscal Q3 2026 earnings report released after market close on April 30.

The company posted earnings per share (EPS) of $2.72, easily surpassing analyst expectations of $2.36, while revenue reached $3.34 billion, ahead of the projected $3.23 billion. Western Digital delivered another standout quarter, with third-quarter revenue soaring 45% year-over-year and non-GAAP gross margin exceeding 50% for the first time in company history.

For fiscal Q4 2026, management guided for midpoint revenue of $3.65 billion, non-GAAP gross margin of approximately 51.5%, and diluted non-GAAP EPS of around $3.25 — all signaling continued operational momentum.

Analyst Upgrades Fuel WDC’s Bullish Momentum

Western Digital’s blockbuster performance triggered a broad wave of analyst upgrades and aggressive price target increases.

  • Baird raised its target to $450 from $310
  • Goldman Sachs increased its target to $400 from $250
  • TD Cowen boosted its target to $500 from $325
  • Mizuho lifted its target to $470 from $400
  • Cantor Fitzgerald raised its target to $660 from $500
  • Argus maintained its Buy rating with a $500 target

This flood of bullish revisions reinforced investor confidence that Western Digital remains one of the strongest beneficiaries of the AI-driven data infrastructure boom.

On the insider activity front, recent SEC filings revealed Form 144 notices for intended sales of restricted stock on May 1 and May 4, 2026. While insider selling can sometimes raise caution, the filings were viewed as only a modest counterbalance to the overwhelmingly bullish momentum.

AI Storage Demand and Cloud Growth Drive Structural Tailwinds

The broader market also supported today’s rally, with the S&P 500 gaining 0.86%, NASDAQ rising 1.02%, and the Dow Jones advancing 0.65%.

Western Digital’s growth story is increasingly tied to booming AI infrastructure demand. The company is strategically positioned within the data ecosystem through its focus on high-capacity hard disk drives designed to support AI workloads. As AI adoption accelerates, hyperscale cloud providers and data centers continue expanding storage capacity, creating a long-term structural demand driver for Western Digital’s products.

In addition to its revenue outperformance, Western Digital increased its dividend by 20%, further signaling management’s confidence in future cash flow strength.

Record Financial Performance Strengthens Long-Term Outlook

Western Digital’s fiscal Q3 FY2026 report showcased:

  • 45.5% annual revenue growth
  • Record non-GAAP gross margin above 50%
  • Above-consensus Q4 guidance
  • 20% dividend increase
  • Multi-year customer agreements extending through 2028 and 2029

Management also provided enhanced visibility into long-term agreements with key cloud customers, giving investors greater confidence in future revenue stability.

Is WDC Still Undervalued?

With Western Digital’s stock rallying sharply, investors are increasingly asking whether shares remain attractively priced.

One of the fastest ways to assess this is through fair value analysis tools that combine multiple valuation models to estimate whether WDC is trading below or above intrinsic value. By comparing WDC against thousands of other stocks, investors may uncover whether Western Digital still offers upside — or if other hidden opportunities present stronger potential.